Bernd Schroter

Title: Bernd Schroter: Innovator in Ergoline Compounds

Introduction

Bernd Schroter is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of ergoline compounds. His work has implications for various medical applications, showcasing the importance of innovation in the pharmaceutical industry.

Latest Patents

Bernd Schroter holds a patent for "2, 13-disubstituted ergolines, their production and use in pharmaceutical agents." This patent describes compounds of formula I and their acid addition salts, detailing a process and intermediates for their production. The compounds have potential applications in the development of pharmaceutical agents, highlighting the innovative nature of his work.

Career Highlights

Throughout his career, Bernd has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has allowed him to focus on the synthesis and application of novel compounds, contributing to advancements in medical treatments.

Collaborations

Bernd has collaborated with notable colleagues, including Gerhard Sauer and Thomas Brumby. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.

Conclusion

In summary, Bernd Schroter is a distinguished inventor whose work in ergoline compounds has the potential to impact the pharmaceutical industry significantly. His contributions, along with his collaborations, underscore the importance of innovation in developing new medical treatments.